FDA Inspection
Anuj Bhargava MDAnuj Bhargava MD – FDA Inspection, Apr 24, 2026
Record Details
This FDA Inspection record concerns Anuj Bhargava MD, with an inspection on April 24, 2026, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · 147b5e1c-4be4-4ecb-bd23-e08f6ea426b2
Inspection Facts
- Inspection number
- 1314648
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anuj Bhargava MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2020 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 7, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 18, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Anuj Bhargava MD
- FDA Inspection 1134357 - 2020-12-17
- FDA Inspection 1108759 - 2019-09-27
- FDA Inspection 1009644 - 2017-04-07
- FDA Inspection 866334 - 2014-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.